Gastric Cancer Adenocarcinoma Metastatic

11 clinical trials · Condition

Record	Firm	Date
Conversion Effects of PD-1 Antibody Camrelizumab Combined With Nab-POF Regimen Chemotherpy in Patients With Initially Unresectable Locally Advanced or Limited Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma：FDZL-GC001 Trial (NCT04510064)	Fudan University	2021-01-06
Docetaxel+Oxali+/-Cetux Met Gastric/GEJ (NCT00517829)	US Oncology Research	2007-07-01

Every clearance here is in the API, with alerts when new ones post.